Abstract:Abstract The innate immune system is the first line of host defense and against viral pathogens via effector molecules, such as type-I interferon (IFN-α/β). Plasmacytoid dendritic cells (pDC) and monocyte-derived DC (moDC) are potent producers of IFN in response to viruses through the respective activation of recognition toll-like receptors (TLRs) and cytosolic RNA helicases MDA5 and RIG-I. Exposure to environmental tobacco smoke (ETS) is a risk factor associated with an increase in the frequency and severity of respiratory infections. However, the mechanisms by which ETS alters innate immune responses have not been fully elucidated. Therefore, we investigated the ability of pDC and moDC to respond to respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in the presence of cigarette smoke extract (CSE). In viral infected pDC and moDC, CSE led to a significant dose-dependent decrease in IFN-α production and in pDC alone cytokines IL-10 and IP-10. CSE treatment attenuated IFN induction by TLR agonists TLR7 and TLR9 in pDC and TLR3 in moDC. CSE also significantly decreased TLR7 and TLR9 gene expression in viral infected pDC. In hMPV infected moDC, the presence of CSE down regulated the gene and protein expression of both MDA5 and RIG-I and phosphorylation of PKR regulated eukaryotic initiation factor-2alpha (eIF2α). Overall, these findings provides novel evidence of the IFN signaling pathways abrogated by CSE in viral infected pDC and moDC.

Cigarette smoke suppresses the anti-viral capacity of dendritic cells (94.7)